ISZO CAPITAL MANAGEMENT LP
Follow13F filer, CIK 1607925, NEW YORK, NY
ISZO CAPITAL MANAGEMENT LP reported $84,294,000 across 5 holdings for the quarter ended 2022-03-31, in a 13F-HR filed 2022-05-16.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001567619-22-011007
- Period
- 2022-03-31
- Reported value
- $84.3M
- Holdings
- 5
- Top 10 weight
- 100%
- New
- 1
- Sold out
- 3
Part of the filer group ISZO CAPITAL LP
ISZO CAPITAL LPBrian L. Sheehy
- ISZO CAPITAL LP
- Brian L. Sheehy
- IsZo Capital GP LLC
Stakes and trades reported after 2022-03-31
13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.
- LQDA LIQUIDIA CORPORATION: 13G 4,712,900 shares, 5.2% of the class, 13G filed 2026-11-19, 0001013594-26-001217Timeline
Accepted , ingested
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| CBLnew | +131,100 | $4.31M |
| NTPIFadded | +546,010 | $3.41M |
| LFCRadded | +251,638 | $801K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| NOTVreduced | -1,010,781 | -$96.3M |
| AVID BIOSERVICES INCexited | -2,208,313 | -$64.4M |
| XPELexited | -103,860 | -$7.09M |
| CCELreduced | -125,824 | -$960K |
| CORBFexited | -1,000 | -$4K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q1 2022
Share positions as resolved from 13F-HR 0001567619-22-011007, largest first. % of portfolio is the value over $84,294,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| NTPIFNAM TAI PROPERTY INC | 7,219,372 | $45.1M | 53.53% | +546,010 | Timeline | ||
| NOTVINOTIV INC | 264,598 | $25.2M | 29.91% | -1,010,781 | Timeline | ||
| LFCRLIFECORE BIOMEDICAL INC | 2,176,949 | $6.93M | 8.22% | +251,638 | Timeline | ||
| CBLCBL & ASSOC PPTYS INC | 131,100 | $4.31M | 5.12% | new | Timeline | ||
| CCELCRYO-CELL INTL INC | 357,107 | $2.73M | 3.23% | -125,824 | Timeline |
Sold out in Q1 2022
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| AVID BIOSERVICES INCAVID BIOSERVICES INC | 2,208,313 | $64.4M | shares |
| XPELXPEL INC | 103,860 | $7.09M | shares |
| CORBFGLOBAL CORD BLOOD CORP | 1,000 | $4K | shares |
How Q1 2022 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001567619-22-011007 | base | 2022-05-16 | acceptance time not in the bulk data set |